GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

J Frontier Co 2934.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

1,924

+1.26%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥22.24bn

FY2019FY2026

Net income

−¥321.3m

FY2019FY2026

Free cash flow

¥395.2m

FY2019FY2026

Shareholders' equity

¥1.23bn

FY2019FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue¥22.24bn¥21.50bn¥17.71bn¥16.84bn¥11.88bn¥8.49bn¥7.11bn¥6.13bn
Research and development——¥74.0m¥107.0m¥8.2m¥129.8m¥51.8m—
Operating income¥310.0m¥293.7m−¥553.0m−¥1.82bn¥731.2m¥671.9m¥170.4m¥368.2m
Net income−¥321.3m¥87.6m−¥2.09bn−¥1.90bn¥400.5m¥424.9m¥96.4m¥6.1m
Diluted earnings per share-60.2116.60-409.10-386.8987.4090.1418.061.15

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets¥9.59bn¥9.17bn¥11.41bn¥7.25bn¥6.10bn¥2.59bn¥2.03bn¥1.91bn
Cash and short-term investments¥2.16bn¥2.17bn¥1.81bn¥1.65bn¥2.96bn¥1.64bn¥908.1m¥953.1m
Total liabilities¥8.05bn¥7.16bn¥9.53bn¥4.54bn¥1.94bn¥1.33bn¥1.19bn¥1.16bn
Debt¥5.31bn¥4.34bn¥5.16bn¥2.14bn¥544.4m¥75.2m¥168.9m¥269.1m
Shareholders' equity¥1.23bn¥1.41bn¥1.14bn¥2.48bn¥4.14bn¥1.27bn¥842.8m¥745.5m
Shares outstanding5m5m5m5m5m5m5m5m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations¥454.3m¥509.0m−¥1.44bn−¥1.83bn−¥366.9m¥830.9m¥218.3m¥14.0m
Capital spending−¥59.1m−¥61.8m−¥108.9m−¥104.7m−¥10.5m−¥6.9m−¥5.1m−¥47.4m
Free cash flow¥395.2m¥447.2m−¥1.54bn−¥1.94bn−¥377.4m¥824.0m¥213.2m−¥33.4m

Latest quarters

By quarter end

Aug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024
Revenue¥5.90bn¥5.85bn¥5.71bn¥5.67bn¥5.00bn¥5.16bn¥5.51bn¥5.42bn
Operating income¥83.7m¥7.7m¥446.9m−¥127.1m−¥17.4m¥92.0m¥70.2m¥113.0m
Net income−¥10.2m−¥405.7m¥275.8m−¥155.4m−¥36.0m−¥34.0m¥113.3m¥26.0m
Diluted earnings per share-1.92-76.0351.68-29.46-6.83-6.4521.485.10
Cash from operations—¥454.0m——————
Capital spending—−¥59.0m——————
Free cash flow—¥395.0m——————
Total assets¥9.59bn¥9.59bn¥10.39bn¥9.86bn¥8.83bn¥9.17bn¥9.05bn¥9.14bn
Cash and short-term investments¥2.03bn¥2.16bn¥2.45bn¥2.07bn¥1.89bn¥2.17bn¥1.75bn¥1.88bn
Debt¥3.27bn¥5.30bn¥3.22bn¥4.86bn¥2.31bn¥4.33bn¥2.41bn¥4.93bn
Shareholders' equity¥1.20bn¥1.23bn¥1.69bn¥1.40bn¥1.37bn¥1.41bn¥1.26bn¥1.16bn

Financial ratios

Data as of 10 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin1.4%1.4%-9.2%-10.9%5.9%8.0%—
Net margin-1.4%0.4%-11.8%-11.3%3.4%5.0%—
Return on equity-26.2%6.2%-183.1%-76.7%9.7%33.5%—
Return on assets-3.4%1.0%-18.3%-26.2%6.6%16.4%—
Free cash flow yield4.9%5.4%-13.1%-17.7%-3.9%8.9%—
Revenue growth3.4%21.4%5.2%41.8%39.8%19.5%—
Earnings growth-466.9%-104.2%9.8%-574.4%-5.7%340.9%—
Current ratio1.07x1.19x1.20x1.55x3.41x1.83x—
Debt to equity4.32x3.08x4.52x0.86x0.13x0.06x—
Equity ratio12.8%15.3%10.0%34.2%67.8%48.9%—
Interest coverage3.58x5.19x-59.81x-165.25x484.39x891.94x—
R&D as a share of sales——0.4%0.6%0.1%1.5%0.7%
Buybacks as a share of market value-0.4%-3.4%-3.9%-7.2%2.8%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.7%21.2%—
Operating income—-14.3%—
Net income-44.7%——

Average margins

Over each period

1 year3 years5 years10 years
Operating margin1.4%-2.3%-0.4%—
Net margin-0.5%-5.4%-3.4%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Price to earnings-31.979.9-3.1-11.132.023.3
Price to sales0.50.30.41.31.11.2

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.